MORGENTHALER VENTURE PARTNERS IX LP's Net Worth
$287 Million
Who is MORGENTHALER VENTURE PARTNERS IX LP?
MORGENTHALER VENTURE PARTNERS IX LP has an estimated net worth of $287 Million. This is based on reported shares across multiple companies, which include Doximity, Inc., Calithera Biosciences, Inc., VAPOTHERM INC, Ra Pharmaceuticals, Inc., and Principia Biopharma Inc..
SEC CIK
MORGENTHALER VENTURE PARTNERS IX LP's CIK is 0001439101
Past Insider Trading and Trends
2014 was MORGENTHALER VENTURE PARTNERS IX LP's most active year for acquiring shares with 6 total transactions. MORGENTHALER VENTURE PARTNERS IX LP's most active month to acquire stocks was the month of September. 2016 was MORGENTHALER VENTURE PARTNERS IX LP's most active year for disposing of shares, totalling 5 transactions. MORGENTHALER VENTURE PARTNERS IX LP's most active month to dispose stocks was the month of October. 2014 saw MORGENTHALER VENTURE PARTNERS IX LP paying a total of $21,619,150.00 for 3,973,830 shares, this is the most they've acquired in one year. In 2016 MORGENTHALER VENTURE PARTNERS IX LP cashed out on 16,880,785 shares for a total of $4,420.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Doximity, Inc. (DOCS) Snapshot price: $36.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 8.54M |
—
|
—
| 8.54M |
Nov 10 - Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 2.16M |
$10.00 | $21,619,150.00 | 2.16M |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VAPOTHERM INC (VAPO) Snapshot price: $2.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 982.69K |
—
|
—
| 982.69K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ra Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15,918.24% | 2.73M |
$11.75 | -$4,420.00 | 2.75M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Principia Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||